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Recent evidence suggests involvement of transient recep-
tor potential (TRP)-related cation channels in cardiac
physiology and pathophysiology, with TRPC3 as one
potential key player in cardiac hypertrophy. It has been
suggested that TRPC3 is upregulated in hypertrophy
development and contributes to Ca2+ signals that govern
pathological remodelling. As TRPC proteins form nonse-
lective cation channels, we hypothesized that these mole-
cules determine not only Ca2+-mediated gene expression
but also excitability and basic electrical properties of the
myocardium in pathological states. We utilized the patch
clamp technique to characterize the electrical remodelling
associated with enhanced TRPC3 expression in cardiac
myocytes. The murine HL-1 atrial cell model, which was
found to express both TRPC3 and TRPC6 at low levels
along with typical signalling partners of TRPC proteins
such as Na+/Ca2+-exchanger-1 and CaV1.2, was modified
to overexpress a functional YFP-TRPC3 fusion protein.
TRPC3 over-expressing cells displayed substantially
altered electrical properties even in the absence of TRPC-
activating stimuli, as evident from a significant shortening
of basal action potential duration and impaired fre-
quency-dependent adaptation of action potential shape.
Action potential-clamp experiments as well as mathemat-
ical modelling attempts were performed to delineate the
consequences of TRPC3 overexpression and to analyze the
mechanisms of TRPC3-mediated electrical remodelling in
the heart. Our results suggest a pivotal role of TRPC chan-
nels in cardiac electrical remodelling associated with
maladaptive hypertrophy.
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